IPL-therapy in ophthalmology: literature review

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

INTRODUCTION: In the modern world, the prevalence of ophthalmological diseases is steadily growing and remains a pressing problem today. Various congenital anomalies of the lacrimal glands, contaminated environment, unbalanced nutrition, taking various medical drugs, wearing contact lenses, irrational use of digital/electronic devices are provoking factors in the development of eye pathology. Chronic processes of the eyelids, such as dry eye syndrome, dysfunction of meibomian glands, blepharitis, blepharoconjunctivitis, recurrent chalazions, significantly reduce the quality of life and working capacity of patients. Disorder in stability of the tear film entails a cascade of pathological alterations. Conservative therapy — artificial tears, thermal applications, anti-inflammatory drugs, antiseptics, antibiotics are unable to provide complete long-term elimination of objective and subjective symptoms. One latest achievement in ophthalmology for these conditions is the use of intense pulsed light (IPL) therapy.

AIM: To analyze domestic and foreign literature sources on the use of IPL-therapy in ophthalmology, to determine the mechanism of its action, effectiveness of this treatment method, its advantages and disadvantages, as well as the possibility to use it for various eye pathologies.

The review summarizes the clinical results of the use of IPL-therapy in ophthalmology, discusses the possibilities of its incorporation in the algorithm of complex treatment of some ophthalmological diseases.

CONCLUSION: IPL-therapy is an effective and safe procedure in some chronic diseases of the anterior segment of the eye.

Full Text

Restricted Access

About the authors

Rozaliya V. Gaybaryan

Rostov State Medical University

Email: rvf1983gr@mail.ru
ORCID iD: 0000-0001-8353-8380
SPIN-code: 9465-2917

MD, Cand. Sci. (Med.)

Russian Federation, Rostov-on-Don

Yuriy B. Fedoseyev

Academy of Postgraduate Education

Author for correspondence.
Email: yura.fedoseev@inbox.ru
ORCID iD: 0009-0009-8834-2075
SPIN-code: 1826-0672
Russian Federation, Moscow

Eric V. Vardanyan

Rostov State Medical University

Email: vardanian.erik2014@yandex.ru
ORCID iD: 0000-0002-1264-7616
SPIN-code: 7343-3556
Russian Federation, Rostov-on-Don

Bella V. Vardanyan

Rostov State Medical University

Email: vardanyan.belah@yandex.ru
ORCID iD: 0009-0004-8475-3858
SPIN-code: 3692-8344
Russian Federation, Rostov-on-Don

References

  1. Toyos R, McGill W, Briscoe D. Intense pulsed light treatment for dry eye disease due to meibomian gland dysfunction; A 3-year retrospective study. Photomed Laser Surg. 2015;33(1):41–6. doi: 10.1089/pho.2014.3819
  2. Loshkareva AO, Maychuk DY. Effectiveness of intense pulsed light in complex treatment of blepharitis and dry eye syndrome with meibomian gland dysfunction. Sovremennyye Tekhnologii v Oftal’mologii. 2019;(3):124–6. (In Russ). doi: 10.25276/2312-4911-2019-3-124-126
  3. Litvin I, Zumbulidze N, Parfenova M. Dry eye syndrome: «retribution» for progress. Vrach. 2022;33(7):77–81. (In Russ). doi: 10.29296/25877305-2022-07-16
  4. Tashbayev B, Yazdani M, Arita R, et al. Intense pulsed light treatment in meibomian gland dysfunction: A concise review. Ocul Surf. 2020;18(4):583–94. doi: 10.1016/j.jtos.2020.06.002
  5. Vergés C, Salgado–Borges J, de Ribot FM. Prospective evaluation of a new intense pulsed light, thermaeye plus, in the treatment of dry eye disease due to meibomian gland dysfunction. J Optom. 2021;14(2):103–13. doi: 10.1016/j.optom.2020.08.009
  6. Dell SJ. Intense pulsed light for evaporative dry eye dis ease. Clin Ophthalmol. 2017;11:1167–73. doi: 10.2147/opth.s139894
  7. Maychuk DYu, Loshkareva AO, Tsvetkova TV. The Complex Treatment Algorithm for Dry Eye Syndrome with Meibomian Gland Dysfunction. Combination of Intense Pulsed Light (IPL) with Eyelid Hygiene and Artificial Tears. Ophthalmology in Russia. 2020;17(3s):640–7. (In Russ). doi: 10.18008/1816-5095-2020-3S-640-647
  8. Song Y, Yu S, He X, et al. Tear film interferometry assessment after intense pulsed light in dry eye disease: A randomized, single masked, sham-controlled study. Cont Lens Anterior Eye. 2022;45(4):101499. doi: 10.1016/j.clae.2021.101499
  9. Suwal A, Hao J–L, Zhou D–D, et al. Use of Intense Pulsed Light to Mitigate Meibomian Gland Dysfunction for Dry Eye Disease. Int J Med Sci. 2020;17(10):1385–92. doi: 10.7150/ijms.44288
  10. Leng X, Shi M, Liu X, et al. Intense pulsed light for meibomian gland dysfunction: a systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol. 2021;259(1):1–10. doi: 10.1007/s00417-020-04834-1
  11. Karaca EE, Evren Kemer Ö, Özek D. Intense Regulated Pulse Light for the Meibomian Gland Dysfunction. Eur J Ophthalmol. 2020;30(2):289–92. doi: 10.1177/1120672118817687
  12. Wladis EJ, Aakalu VK, Foster JA, et al. Intense Pulsed Light for Meibomian Gland Disease: A Report by the American Academy of Ophthalmology. Ophthalmology. 2020;127(9):1227–33. doi: 10.1016/j.ophtha.2020.03.009
  13. Fishman HA, Periman LM, Shah AA. Real-Time Video Microscopy of In Vitro Demodex Death by Intense Pulsed Light. Photobiomodul Photomed Laser Surg. 2020;38(8):472–6. doi: 10.1089/photob.2019.4737
  14. Zhu Y, Huang X, Lin L, et al. Efficacy of Intense Pulsed Light in the Treatment of Recurrent Chalaziosis. Front Med (Lausanne). 2022;9:839908. doi: 10.3389/fmed.2022.839908
  15. Ruan F, Zang Y, Sella R, et al. Intense Pulsed Light Therapy with Optimal Pulse Technology as an Adjunct Therapy for Moderate to Severe Blepharitis-Associated Keratoconjunctivitis. J Ophthalmol. 2019;2019:3143469. doi: 10.1155/2019/3143469
  16. Gedar Totuk ÖM, Kabadayı K, Özkapı C, et al. Efficacy of Intense Pulsed Light Treatment for Moderate to Severe Acute Blepharitis or Blepharoconjunctivitis: A Retrospective Case Series. Turk J Ophthalmol. 2021;51(2):89–94. doi: 10.4274/tjo.galenos.2020.28924
  17. Li D, Lin S–B, Cheng L–H–H, et al. Intense Pulsed Light Treatment for Itch Associated with Allergic Keratoconjunctivitis: A Retrospective Study of 35 Cases. Photobiomodul Photomed Laser Surg. 2021;39(3):196–203. doi: 10.1089/photob.2020.4826
  18. Toyos М, Toyos R, Jodoin B, et al. Results from a Prospective, Open-Label, Phase 4 Pilot Study of Repository Corticotropin Injection for Moderate and Severe Dry Eye Disease. Ophthalmol Ther. 2022;11(3):1231–40. doi: 10.1007/s40123-022-00501-2

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2025 Eco-Vector


Media Registry Entry of the Federal Service for Supervision of Communications, Information Technology and Mass Communications (Roskomnadzor) PI No. FS77-76803 dated September 24, 2019.